NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 10 filers reported holding NLS PHARMACEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $239,807 | +15.8% | 826,921 | -0.1% | 0.08% | +23.4% |
| Q3 2022 | $207,000 | +109.1% | 827,421 | 0.0% | 0.06% | +146.2% |
| Q2 2022 | $99,000 | -91.5% | 827,421 | -0.1% | 0.03% | -90.9% |
| Q1 2022 | $1,167,000 | +27.0% | 827,921 | 0.0% | 0.29% | +2.1% |
| Q4 2021 | $919,000 | -55.6% | 827,921 | 0.0% | 0.28% | -35.6% |
| Q3 2021 | $2,069,000 | +137.3% | 827,921 | 0.0% | 0.44% | +177.1% |
| Q2 2021 | $872,000 | – | 827,921 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 170,100 | $17,895 | 0.12% |
| Altium Capital Management LP | 200,000 | $21,040 | 0.01% |
| ARMISTICE CAPITAL, LLC | 500,000 | $52,600 | 0.00% |
| CLEAR STREET LLC | 8,600 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Hudson Bay Capital Management LP | 200,000 | $21,040 | 0.00% |